Determination of Drug Levels for Pharmacotherapy of Heart Failure
Status:
NOT_YET_RECRUITING
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine whether and how serum concentrations of the used medicinal products, including their metabolites, correlate with selected clinical indicators of heart failure (NT-proBNP concentration, 6-minute walk test, quality of life questionnaire, echocardiographic parameters, hospitalization for HFrEF, length of survival).
Phase:
PHASE4
Details
Lead Sponsor:
University Hospital Ostrava
Treatments:
Bisoprolol Carvedilol Metoprolol Nebivolol sacubitril and valsartan sodium hydrate drug combination Spironolactone